The Language/AI Incubator, an MIT Human Insight Collaborative project, is investigating how AI can improve communications among patients and practitioners.

The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.

Launched with a gift from the Biswas Family Foundation, the Biswas Postdoctoral Fellowship Program will support postdocs in health and life sciences.

In an analysis of over 160,000 transplant candidates, researchers found that race is linked to how likely an organ offer is to be accepted on behalf of a patient.

The Substance Use Disorders Ventures Bootcamp ignites innovators like Evan Kharasch to turn research breakthroughs into treatments for substance use disorder.

Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.

Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.

The approach collects multiple types of imaging and sequencing data from the same cells, leading to new insights into mouse liver biology.

The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.

Researchers find nonclinical information in patient messages — like typos, extra white space, and colorful language — reduces the accuracy of an AI model.

Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.

Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.

The BiophysicaL Immune Profiling for Infants (BLIPI) profiles an infant’s immune system in under 15 minutes, using just a single drop of blood.

A new book by Thomas Levenson examines how germ theory arose, launched modern medicine, and helped us limit fatal infectious diseases.

The MIT Ethics of Computing Research Symposium showcases projects at the intersection of technology, ethics, and social responsibility.

The ingestible capsule forms a drug depot in the stomach, gradually releasing its payload and eliminating the need for patients to take medicine every day.

The winning essay of the Envisioning the Future of Computing Prize puts health care disparities at the forefront.

MIT study finds an easily measurable brain wave shift may be a universal marker of unconsciousness under anesthesia.

Courses on developing AI models for health care need to focus more on identifying and addressing bias, says Leo Anthony Celi.

Researchers also found these effects can be reversed by treatment with an antioxidant.

The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.

Pathways involved in DNA repair and other cellular functions could contribute to the development of Alzheimer’s.

One combination of methods led to a 44 percent increase in child immunizations.

Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.

MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.

Words like “no” and “not” can cause this popular class of AI models to fail unexpectedly in high-stakes settings, such as medical diagnosis.

The new design could assist the elderly as they age in place at home.

Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.

Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.

MIT chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world’s deadliest pathogen.

Informal help is a huge share of elder care in the U.S., a burden that is only set to expand. A new book explores different countries’ solutions.

Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.

Scaling up nanoparticle production could help scientists test new cancer treatments.

Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.

When scientists stimulated cells to produce a protein that helps “water bears” survive extreme environments, the tissue showed much less DNA damage after radiation treatment.

Stefani Spranger is working to discover why some cancers don’t respond to immunotherapy, in hopes of making them more vulnerable to it.

When his son received a devastating diagnosis, Fernando Goldsztein MBA ’03 founded an initiative to help him and others.

Four professors and an additional alumnus honored with nation’s highest awards for scientists and engineers; Moderna, with deep MIT roots, also recognized.

Junior Katie Spivakovsky describes her path through New Engineering Education Transformation to biomedical research and beyond.

Ten objects on display in the Koch Institute Public Galleries offer uncommon insights into the people and progress of MIT's cancer research community.

By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.

The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.

The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.

Professors Matthew Vander Heiden and Fan Wang, along with five MIT alumni, are honored for their outstanding professional achievement and commitment to service.

Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.

Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations.

MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.

PhD student Oscar Molina seeks new ways to assemble proteins into targeted cancer therapies, while also encouraging his fellow first-generation graduate students.

Fasting helps intestinal stem cells regenerate and heal injuries but also leads to a higher risk of cancer in mice, MIT researchers report.

The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.